Press Releases< /span>
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 8, 2010
Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the Rodman & Renshaw Annual Global Investment Conference, which...
-
Jul 28, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2010. Q2 2010 Summary --------------- - Net revenue...
-
Jul 8, 2010
- Second quarter financial results to be released July 28, 2010 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 8 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...
-
Jul 7, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it reached a cumulative sales milestone for Lipofen(R), the Company's fenofibrate product. Achieving this target triggers a US$1.0...
-
Jun 4, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today commented on the outcome of the appeal by Purdue Pharma Products L.P. of the decision of the United States District Court for the District of Delaware...
-
May 10, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced the U.S. Food and Drug Administration ("FDA") has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the...
-
Apr 23, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2010. Q1 2010 Summary --------------- - Total revenue increased...
-
Apr 16, 2010
- First quarter financial results to be released April 23, 2010 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, April 16 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Apr 14, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced it will hold its Annual and Special Meeting of Shareholders on Thursday, April 22, 2010 at 4:30 p.m. ET. WHAT: ANNUAL AND SPECIAL MEETING OF...
-
Apr 1, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
Mar 26, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that its New Drug Submission (NDS) to Health Canada for CIP-TRAMADOL ER, its extended-release formulation of tramadol, has been accepted for...
-
Feb 17, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2009. Fiscal 2009 Summary -------------------...
-
Feb 5, 2010
- Fourth quarter and year end financial results to be released February 17, 2010 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 5 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will...
-
Jan 4, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced a final judgment (the "Cipher Judgment") has been entered in favour of Cipher in relation to pending patent litigation with Purdue Pharma...
-
Nov 4, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2009. Q3 2009 Summary --------------- - Total revenue...
-
Nov 3, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Dr. William Claypool, M.D., has been appointed to its Board of Directors. Since October 2008, Dr. Claypool has been a Senior Partner at...
-
Nov 2, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or the "Company") today announced that Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. have filed a complaint against Cipher in the...
-
Oct 26, 2009
- Third quarter financial results to be released November 4, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 26 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Oct 7, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has enrolled the first patient in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
Aug 31, 2009
Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer of the Company, is presenting at Rodman & Renshaw's 11th Annual Healthcare...
-
Jul 29, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2009.Q2 2009 Summary --------------- - Finalized FDA...
-
Jul 20, 2009
- Second quarter financial results to be released July 29, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 20 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...
-
May 13, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2009.Q1 2009 Summary ---------------- - Received tentative U.S....
-
May 7, 2009
- First quarter financial results to be released on May 13, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 7 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...
-
Feb 18, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2008.Fiscal 2008 Summary -------------------...